Index Option Calls
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Index Option Calls
No Result
View All Result
Home Latest News

Moderna shares fall after company cuts 2021 forecast for Covid vaccine sales

by
November 4, 2021
in Latest News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Moderna shares fell by more than 16% on Thursday after it cut its Covid-19 vaccine sales forecast for the year and missed earnings and revenue expectations for the third quarter.

The company said some doses for delivery this year have been shifted to early 2022 amid production issues and as it prioritizes deliveries to low-income countries through COVAX, the U.N.-backed effort to share coronavirus vaccines. It now expects Covid vaccine sales of between $15 billion and $18 billion this year, down from an earlier projection of $20 billion.

RELATED POSTS

Jamie Dimon is being deposed over JPMorgan Chase role in Epstein lawsuits

Here’s where to invest $10,000 right now, according to the pros

In releasing its third-quarter earnings, Moderna said it is now expecting to deliver between 700 million and 800 million doses this year, down from its previous expectations of between 800 million and 1 billion doses. The company also said it projects sales of $17 billion to $22 billion in 2022.

By comparison, Pfizer has said it expects Covid vaccine sales of $36 billion this year and $29 billion in 2022.

Here’s how Moderna did compared with what Wall Street expected, according to average estimates compiled by Refinitiv:

EPS: $7.70 per share versus $9.05 per share expectedRevenue: $4.97 billion versus $6.21 billion expected

“We are humbled to have helped hundreds of millions of people around the world with our COVID-19 vaccine and yet we know our work is not done,” Moderna CEO Stephane Bancel said in a statement.

He said the company is working to ensure the vaccine is available in low-income countries by providing approximately 10% of its 2021 volume to them, and “significantly more” volume next year.

On a post-earnings call with investors, Bancel said the company’s supply chain became “more complex,” impacting international deliveries of its vaccine.

“We’ve increased deliveries to many countries around the world,” he said. “At the beginning of the year, we supplied to just a few large countries.”

Moderna Chief Financial Officer David Meline said the company continues to scale up its production network and is “working to achieve an increase quarter-over-quarter improvement starting in Q4.”

Moderna’s Covid vaccine is the company’s only commercialized product. The earnings report comes two weeks after the Food and Drug Administration authorized booster shots of Moderna’s vaccine to tens of millions of Americans.

The company said Thursday it anticipates commercial booster market sales could be up to $2 billion in 2022.

ShareTweetPin

Related Posts

Jamie Dimon is being deposed over JPMorgan Chase role in Epstein lawsuits

by
March 29, 2023
0

Jamie Dimon, chairman and chief executive officer of JPMorgan Chase & Co., during a Bloomberg Television interview at the JPMorgan...

Here’s where to invest $10,000 right now, according to the pros

by
March 29, 2023
0

Markets have been hit by volatility over the past month leading some retail investors to question where to park their...

Mortgage demand gets a boost from bank volatility, but it may be short-lived

by
March 29, 2023
0

An 'open house' flag is displayed outside a single family home on September 22, 2022 in Los Angeles, California. Allison...

Bitcoin climbs 5% above $28,000 as investors shrug off regulatory crackdowns

by
March 29, 2023
0

In this article BTC.CM= Follow your favorite stocksCREATE FREE ACCOUNT Bitcoin is up 50% so far in 2023, beating major...

IHOP overhauls its menu: Cinn-A-Stack pancakes are back, savory crepes are in

by
March 29, 2023
0

In this article DIN Follow your favorite stocksCREATE FREE ACCOUNT IHOP's new crepe lineup features sweet and savory flavors. Source:...

Next Post

Hotels: Occupancy Rate Down 6% Compared to Same Week in 2019

Bezos' Blue Origin loses lawsuit against NASA over SpaceX lunar lander contract

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:

By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • A Couple Stored IRA Gold at Home. They Owe the IRS More Than $300,000.

    0 shares
    Share 0 Tweet 0
  • A California Couple Spent Eight Years Building Their Dream Retirement Home in Costa Rica

    0 shares
    Share 0 Tweet 0
  • Goldman Sachs says buy these stocks to play Web 3.0 and the metaverse

    0 shares
    Share 0 Tweet 0
  • In his final warning, this stock trading wizard — who made big money in bear markets and crashes — called this market a bubble like no other

    0 shares
    Share 0 Tweet 0
  • Goldman Sachs picks new stocks to buy — and says these 5 have over 100% upside

    0 shares
    Share 0 Tweet 0
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by www.indexoptioncalls.com
No Result
View All Result
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy

All rights reserved by www.indexoptioncalls.com